||EPS - Basic
||Market Cap (m)
Science Sprt Share Discussion Threads
Showing 201 to 222 of 225 messages
|Good to see SM buying shares. Shows confidence in things to come. Tempted to add myself too...(at this level)
|Apologies, the link above didn't work before, It's now fixed.
I C Summary
SIS is a highly speculative offering but recent sales momentum is encouraging. The group boasts a strong and trusted brand in a fast-growing market, which should support forecasts of strong sales growth. This, coupled with central cost controls, should ultimately see profits flow. A speculative buy.|
|Positive review? Not had chance look at it yet|
|SIS given the kiss of death in today's IC
(I hold a few)|
|Agree good to see director purchase today!!! And finally a bit of blue would be nice see this get back to 65, then hopefully we get some updated (good) news drive price higher.|
|Good to see SM buying.
|Thanks bamboo2 but the credit goes to GHF for his excellent research etc.|
|Bull flag confirmed targetting min 76.5 [actually confirmed on previous session]
Well done again BB2!|
|4p up so far today on the Liverpool FC deal.|
|This has just triggered a buy signal at 68, stop loss 66|
|If this is a bullish Pennant chart pattern, the breakout should occur soon. 50sma has just crossed the 200sma which can be seen as a positive. Potential target around 76.5, once the pattern is confirmed with a b/o above the highest point in the Pennant.|
|New highs :))|
|Really pleased with this, I actually bought at 71p so am not in profit like some who had bought at much levels but nearly back to break even. I always believed that this company will grow in the long term so glad I hung in there.|
|Whilst realistically it is only a small portion of the $7B that SIS will be targeting they are still very big numbers. The US market alone is 10x the UK, and all reachable through the platform of the internet. Significant growth opportunity is clearly there. Think this has a long way to go once the potential becomes more widely understood. That's my view anyway which is why I am here.:-)
DYOR, AIMHO etc. etc.
|That market at worth $7 billion is incredible, huge potential for us.|
|Yes excellent response to this mornings news.|
|Morning all- and a very good morning it is too. 😀
|Catching up with events.
Back after hols. No phone or distractions.
Pleased with he t/s and the amount of publicity SIS are achieving via the fantastic Team Sky performance at the Tour de France.
Science In Sport celebrates Team Sky tour win
Science in Sport (SiS) is celebrating the Tour de France victory by Team Sky rider, Chris Froome.
Completing the Tour de France in 89 hours 4 minutes and 48 seconds, Froome took the yellow jersey for the third time, after completing the 21 stage tour. Fuelling Froome and the team to victory in the three-week long competition was SiS, Team Sky’s Official Sports Nutrition Supplier.
It was SiS’ first Tour de France as part of Team Sky and throughout the Grand Tour, riders used SiS around the clock to aid hydration, energy, recovery and immunity. In total, Team Sky riders consumed a staggering:
· 570 GO Energy bars
· 580 GO Isotonic gels
· 180 GO Electrolyte gels
· 240 Go Energy+Caffeine gels
· 940 GO Electrolyte servings
· 180 REGO Rapid Recovery servings
· 210 Overnight protein servings
· 300 GO Hydro servings
Speaking about his success and the importance of nutrition, Froome said: “You push your body to the limit on a Grand Tour like the Tour de France, which is why nutrition is everything. Competing against the best cyclists in the world day after day is the greatest test anyone can endure, both mentally and physically, this is a team victory and not an individual achievement.
“Without the support of the other riders, coaches, staff and partners like SiS, this wouldn’t have been possible. Until you’re in this position, you don’t appreciate the importance of sports nutrition in aiding your performance and the marginal gains that it delivers.
“James and the team ensure that we are kept hydrated and remain fuelled with the right carbohydrates and proteins, as we compete in the greatest Grand Tour in the world. To win is a great achievement for everyone involved.”
Since becoming partners in January 2016, SiS nutrition experts have worked together with Dr James Morton, Head of Nutrition at Team Sky, to create bespoke products and tailored nutritional plans for each rider, to help the team achieve the marginal gains that have crowned them 2016 Tour champions.
Upon victory, James added: “Nutrition is the secret to success of any cycling team. Each product consumed during the Tour was specifically designed by SiS to benefit each athlete’s performance, enabling them to train harder, race faster and recover quicker than competitors”
Ashley Read, marketing director for SiS, said: “Science underpins everything we do and we’re really proud to have fuelled Team Sky to victory in our first year in partnership with them. We have a huge responsibility in fuelling the team to even more success in the years to come. Congratulations Team Sky!”
SiS products are manufactured in the UK at the company’s Innovation Centre in Lancashire. All SiS products are Informed-Sport tested and accredited; SiS worked closely with the HFL anti-doping laboratory to develop a world class evolved three-pronged testing system to minimise the risk of product contamination.
For more information, please visit www.scienceinsport.com.
Also interested to read first reviews of SISs products which have just been launched in the US.
Generally positive and note the focus on Chris Froome via the article. I reckon the Team Sky partnership was a masterstroke and will help propel sales of their products worldwide.
"...the Group has been taking share in the endurance sports nutrition category whilst the products continue to gain traction in new sports. With the Group’s international expansion and customarily important NPD contribution we make no change to our full year forecasts.
In our view the stock appears to be good value trading at 2016F EV/Sales 1.0x when M&A multiples are c 4x. With impressive top line growth already and several international markets providing potentially transformational growth opportunities, we reiterate our BUY recommendation.
|Excellent response to this mornings update.|
|RNS Number : 4747E
Science in Sport PLC
21 July 2016
SCIENCE IN SPORT PLC
("SiS" or the "Company)
Half Year Trading Update
Science in Sport plc (AIM: SIS), a leading sports nutrition company, is pleased to announce the following pre-close trading update ahead of its financial results for the six months ended 30 June 2016.
The Board is pleased to report another period of strong sales growth, and significant progress in execution of the Company's growth strategy.
Sales increased 24% to £6.48 million in the six months to 30 June 2016 compared with the same period for the previous year (H1 2015 £5.24 million). Sales growth was particularly strong via the Company's website and from third party online retailers. Growth in international markets was also strong, and the recently launched Australian business is trading in line with expectations.
The Company increased its database of customers on its own website significantly ahead of target. International expansion of the scienceinsport.com trading platform is to accelerate in the second half of the year, with July seeing websites launch in the new markets of USA and Germany, and native language websites launched in the existing markets of Italy and Holland.
Costs remain tightly controlled and the Company is in a strong financial position with over £6.5 million of net cash, leaving it well placed to exploit further growth opportunities as they arise. The Board remains confident of the outlook for the full year and beyond.
SiS intends to issue its half year results on Thursday 22 September 2016.
Stephen Moon, Science in Sport's CEO, said: "We have had a strong start to the year in a difficult market, and have made very good progress, particularly when many of our competitors have faced growth challenges."
"We have invested heavily in our e-commerce business and in international markets, and together with our strong innovation pipeline, we expect this to underpin the second half of the year."|